- Home
- GLMD vs JXG Comparison
GLMD vs JXG Comparison
Compare GLMD & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- JXG
- Stock Information
- Founded
- GLMD 2000
- JXG N/A
- Country
- GLMD Israel
- JXG China
- Employees
- GLMD N/A
- JXG N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- JXG
- Sector
- GLMD Health Care
- JXG
- Exchange
- GLMD Nasdaq
- JXG Nasdaq
- Market Cap
- GLMD 4.6M
- JXG 5.0M
- IPO Year
- GLMD 2014
- JXG N/A
- Fundamental
- Price
- GLMD $3.03
- JXG N/A
- Analyst Decision
- GLMD
- JXG
- Analyst Count
- GLMD 0
- JXG 0
- Target Price
- GLMD N/A
- JXG N/A
- AVG Volume (30 Days)
- GLMD 47.4K
- JXG 436.1K
- Earning Date
- GLMD 01-03-2025
- JXG 05-12-2025
- Dividend Yield
- GLMD N/A
- JXG N/A
- EPS Growth
- GLMD N/A
- JXG N/A
- EPS
- GLMD N/A
- JXG 0.48
- Revenue
- GLMD N/A
- JXG $31,840,588.00
- Revenue This Year
- GLMD N/A
- JXG N/A
- Revenue Next Year
- GLMD N/A
- JXG N/A
- P/E Ratio
- GLMD N/A
- JXG $1.71
- Revenue Growth
- GLMD N/A
- JXG N/A
- 52 Week Low
- GLMD $2.56
- JXG $0.75
- 52 Week High
- GLMD $23.80
- JXG $8.51
- Technical
- Relative Strength Index (RSI)
- GLMD 49.41
- JXG N/A
- Support Level
- GLMD $2.81
- JXG N/A
- Resistance Level
- GLMD $3.35
- JXG N/A
- Average True Range (ATR)
- GLMD 0.27
- JXG 0.00
- MACD
- GLMD 0.06
- JXG 0.00
- Stochastic Oscillator
- GLMD 56.63
- JXG 0.00
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.